The S&P 500 rebounded from bear market territory earlier this year, prompting consideration of healthcare stocks like Johnson & Johnson (JNJ) and Abbott Laboratories (ABT). Johnson & Johnson’s diversified business and consistent revenue make it a top pick, especially since it boasts the highest credit rating and a 63-year streak of dividend increases.

Abbott Laboratories, another healthcare leader, shows reliable revenue and earnings growth due to its diversified business. Its focus on diabetes care and a recent acquisition in cancer diagnostics position it well for growth. Abbott is also a Dividend King with a 54-year streak of dividend increases, making it an attractive stock to buy in a bear market.

Investors should note that Johnson & Johnson didn’t make The Motley Fool’s list of the 10 best stocks to buy now. However, Stock Advisor’s total average return of 966% outperforms the S&P 500 by a significant margin. Don’t miss out on the latest top 10 list and join an investing community focused on individual investors.

Read more at Yahoo Finance: 2 Healthcare Stocks to Buy in a Bear Market